(+)-catechin decreases expression EXP 6480464 Catechin results in decreased expression of GSTM2 mRNA CTD PMID:19838946 (-)-epigallocatechin 3-gallate increases expression EXP 6480464 epigallocatechin gallate results in increased expression of GSTM2 mRNA, epigallocatechin gallate results in increased expression of GSTM2 protein CTD PMID:10927022 (S)-nicotine decreases expression ISO RGD:10698 6480464 Nicotine results in decreased expression of GSTM2 mRNA CTD PMID:33640489 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane affects expression ISO RGD:10698 6480464 o, p'-DDT affects the expression of GSTM2 mRNA CTD PMID:18925944 1,2-dichloroethane decreases expression ISO RGD:10698 6480464 ethylene dichloride results in decreased expression of GSTM2 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of GSTM2 mRNA CTD PMID:32387197 1,2-dimethylhydrazine multiple interactions ISO RGD:10698 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:10698 6480464 1, 2-Dimethylhydrazine results in decreased expression of GSTM2 mRNA CTD PMID:22206623 1,4-dioxane increases expression ISO RGD:10698 6480464 1, 4-dioxane results in increased expression of GSTM2 mRNA CTD PMID:33693819 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression EXP 6480464 chlorcyclizine results in increased expression of GSTM2 mRNA CTD PMID:21058326 1-chloro-2,4-dinitrobenzene affects metabolic processing ISO RGD:735264 6480464 GSTM2 protein affects the metabolism of Dinitrochlorobenzene CTD PMID:3570286 1-chloro-2,4-dinitrobenzene multiple interactions EXP 6480464 Dinitrochlorobenzene promotes the reaction [GSTM2 protein affects the metabolism of Glutathione] CTD PMID:9794801 1-chloro-2,4-dinitrobenzene affects activity EXP 6480464 Dinitrochlorobenzene affects the activity of GSTM2 protein CTD PMID:9794801 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of GSTM2 protein CTD PMID:9794801 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of GSTM2 mRNA CTD PMID:18289764 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of GSTM2 mRNA CTD PMID:12655037 , PMID:15576828 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of GSTM2 mRNA CTD PMID:12082028 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GSTM2 mRNA CTD PMID:31119341 2,2',4,4',5,5'-hexachlorobiphenyl increases expression ISO RGD:10698 6480464 2 more ... CTD PMID:21851831 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:10698 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:20056577 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:735264 6480464 2 more ... CTD PMID:31675489 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of GSTM2 protein CTD PMID:12361703 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10698 6480464 Tetrachlorodibenzodioxin results in increased expression of GSTM2 mRNA CTD PMID:18172886 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10698 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of GSTM2 mRNA more ... CTD PMID:16214954 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10698 6480464 Tetrachlorodibenzodioxin affects the expression of GSTM2 mRNA CTD PMID:20702594 , PMID:26377647 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO RGD:10698 6480464 2 more ... CTD PMID:20702594 2,4,6-trinitrobenzenesulfonic acid decreases expression ISO RGD:10698 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of GSTM2 mRNA CTD PMID:17982090 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of GSTM2 mRNA CTD PMID:21346803 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of GSTM2 mRNA CTD PMID:21346803 2,6-di-tert-butyl-4-methylphenol increases expression EXP 6480464 Butylated Hydroxytoluene results in increased expression of GSTM2 mRNA CTD PMID:12082028 , PMID:18539377 2-allylphenol decreases activity EXP 6480464 2-allylphenol results in decreased activity of GSTM2 protein CTD PMID:8620581 2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid decreases expression EXP 6480464 Nafenopin results in decreased expression of GSTM2 protein CTD PMID:8914623 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:10698 6480464 [3 more ... CTD PMID:24378064 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:10698 6480464 3 more ... CTD PMID:18042819 3,3',4,4',5-pentachlorobiphenyl affects expression ISO RGD:10698 6480464 3 more ... CTD PMID:20702594 3,5-diethoxycarbonyl-1,4-dihydrocollidine increases expression ISO RGD:10698 6480464 Dicarbethoxydihydrocollidine results in increased expression of GSTM2 mRNA CTD PMID:18098314 3,5-diethoxycarbonyl-1,4-dihydrocollidine multiple interactions ISO RGD:10698 6480464 S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of GSTM2 mRNA] CTD PMID:18098314 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of GSTM2 protein CTD PMID:26072098 , PMID:34915118 3H-1,2-dithiole-3-thione multiple interactions ISO RGD:10698 6480464 [1, 2-dithiol-3-thione results in increased activity of NFE2L2 protein] which results in increased expression of GSTM2 mRNA CTD PMID:22495766 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1, 2-dithiol-3-thione results in increased expression of GSTM2 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO RGD:10698 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of GSTM2 mRNA CTD PMID:18648102 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of GSTM2 mRNA CTD PMID:18289764 4,4'-sulfonyldiphenol increases expression ISO RGD:10698 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GSTM2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases expression ISO RGD:735264 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GSTM2 protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions ISO RGD:10698 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of GSTM2 mRNA CTD PMID:30951980 4-Chloronitrobenzene multiple interactions EXP 6480464 GSTM2 protein affects the metabolism of [4-chloronitrobenzene analog co-treated with Glutathione] CTD PMID:8973562 4-hydroxynon-2-enal multiple interactions EXP 6480464 [GSTM1 protein binds to GSTM2 protein] which affects the metabolism of 4-hydroxy-2-nonenal analog CTD PMID:11256969 4-hydroxynon-2-enal decreases response to substance ISO RGD:735264 6480464 GSTM2 protein results in decreased susceptibility to 4-hydroxy-2-nonenal CTD PMID:15829614 4-hydroxynon-2-enal affects metabolic processing EXP 6480464 GSTM2 protein affects the metabolism of 4-hydroxy-2-nonenal analog CTD PMID:11256969 4-hydroxyphenyl retinamide increases expression ISO RGD:10698 6480464 Fenretinide results in increased expression of GSTM2 mRNA CTD PMID:28973697 4-Propylphenol decreases activity EXP 6480464 4-propylphenol results in decreased activity of GSTM2 protein CTD PMID:8620581 5-aza-2'-deoxycytidine multiple interactions ISO RGD:735264 6480464 [Decitabine affects the methylation of GSTM2 promoter] which affects the expression of GSTM2 mRNA more ... CTD PMID:18664505 , PMID:21246532 5-aza-2'-deoxycytidine increases expression ISO RGD:735264 6480464 Decitabine results in increased expression of GSTM2 mRNA CTD PMID:19900515 , PMID:21246532 8'-apo-beta,psi-caroten-8'-al decreases expression ISO RGD:735264 6480464 apocarotenal results in decreased expression of GSTM2 mRNA CTD PMID:17034753 8-Br-cAMP decreases expression ISO RGD:735264 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of GSTM2 mRNA CTD PMID:22079614 aflatoxin B1 decreases expression ISO RGD:10698 6480464 Aflatoxin B1 results in decreased expression of GSTM2 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of GSTM2 mRNA CTD PMID:33354967 all-trans-retinoic acid decreases expression ISO RGD:10698 6480464 Tretinoin results in decreased expression of GSTM2 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO RGD:735264 6480464 Tretinoin results in decreased expression of GSTM2 mRNA CTD PMID:33167477 all-trans-retinoic acid multiple interactions ISO RGD:10698 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Tretinoin] results in decreased expression of GSTM2 mRNA CTD PMID:30951980 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of GSTM2 mRNA CTD PMID:16483693 ampicillin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA CTD PMID:30545405 andrographolide multiple interactions ISO RGD:10698 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM2 mRNA CTD PMID:19737545 antimycin A decreases expression ISO RGD:735264 6480464 Antimycin A results in decreased expression of GSTM2 mRNA CTD PMID:33512557 arsane affects methylation ISO RGD:735264 6480464 Arsenic affects the methylation of GSTM2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:735264 6480464 Arsenic affects the methylation of GSTM2 gene CTD PMID:25304211 astaxanthin multiple interactions ISO RGD:735264 6480464 [astaxanthine co-treated with Docosahexaenoic Acids] results in increased expression of GSTM2 mRNA, [astaxanthine co-treated with Eicosapentaenoic Acid] results in increased expression of GSTM2 mRNA CTD PMID:24157545 astaxanthin increases expression ISO RGD:735264 6480464 astaxanthine results in increased expression of GSTM2 mRNA CTD PMID:24157545 atrazine increases expression ISO RGD:735264 6480464 Atrazine results in increased expression of GSTM2 mRNA CTD PMID:22378314 atrazine increases expression EXP 6480464 Atrazine results in increased expression of GSTM2 mRNA CTD PMID:28882082 bacitracin increases expression EXP 6480464 Bacitracin results in increased expression of GSTM2 mRNA CTD PMID:18289764 benzo[a]pyrene increases expression ISO RGD:735264 6480464 Benzo(a)pyrene results in increased expression of GSTM2 mRNA CTD PMID:33411230 benzo[a]pyrene decreases expression ISO RGD:735264 6480464 Benzo(a)pyrene results in decreased expression of GSTM2 mRNA CTD PMID:32234424 benzo[a]pyrene increases activity ISO RGD:10698 6480464 Benzo(a)pyrene results in increased activity of GSTM2 protein CTD PMID:30938511 benzo[a]pyrene increases methylation ISO RGD:735264 6480464 Benzo(a)pyrene results in increased methylation of GSTM2 5' UTR, Benzo(a)pyrene results in increased methylation of GSTM2 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:735264 6480464 Benzo(a)pyrene affects the methylation of GSTM2 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:10698 6480464 Benzo(a)pyrene results in decreased expression of GSTM2 mRNA CTD PMID:20127859 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of GSTM2 mRNA CTD PMID:21839799 benzo[a]pyrene increases expression ISO RGD:10698 6480464 Benzo(a)pyrene results in increased expression of GSTM2 mRNA CTD PMID:27195522 , PMID:32417428 benzo[a]pyrene decreases response to substance ISO RGD:735264 6480464 GSTM2 protein results in decreased susceptibility to Benzo(a)pyrene CTD PMID:19900515 benzothiazole increases expression EXP 6480464 benzothiazole results in increased expression of GSTM2 mRNA CTD PMID:8951341 benzylideneacetone affects metabolic processing ISO RGD:10698 6480464 GSTM2 protein affects the metabolism of benzylideneacetone CTD PMID:1859377 beta-carotene increases expression ISO RGD:735264 6480464 beta Carotene results in increased expression of GSTM2 mRNA CTD PMID:17034753 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of GSTM2 mRNA CTD PMID:19695238 beta-naphthoflavone multiple interactions ISO RGD:10698 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in increased expression of GSTM2 mRNA CTD PMID:19737545 bifenthrin increases expression ISO RGD:10698 6480464 bifenthrin results in increased expression of GSTM2 mRNA CTD PMID:26071804 bis(2-chloroethyl) sulfide decreases expression ISO RGD:10698 6480464 Mustard Gas results in decreased expression of GSTM2 mRNA CTD PMID:18955075 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of GSTM2 protein CTD PMID:8914623 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:10698 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of GSTM2 mRNA CTD PMID:25181051 , PMID:30903817 bisphenol A decreases expression ISO RGD:735264 6480464 bisphenol A results in decreased expression of GSTM2 protein CTD PMID:31675489 bisphenol A increases expression ISO RGD:10698 6480464 bisphenol A results in increased expression of GSTM2 mRNA CTD PMID:30951980 bisphenol A multiple interactions ISO RGD:10698 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bisphenol A increases methylation ISO RGD:10698 6480464 bisphenol A results in increased methylation of GSTM2 promoter CTD PMID:27312807 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GSTM2 mRNA CTD PMID:15901920 , PMID:34947998 Bisphenol B increases expression ISO RGD:735264 6480464 bisphenol B results in increased expression of GSTM2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:10698 6480464 bisphenol F results in increased expression of GSTM2 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:735264 6480464 bisphenol F results in increased expression of GSTM2 protein CTD PMID:34186270 bromobenzene affects binding EXP 6480464 bromobenzene metabolite binds to GSTM2 protein CTD PMID:17305373 bromosulfophthalein decreases activity EXP 6480464 Sulfobromophthalein results in decreased activity of GSTM2 protein CTD PMID:8968379 butanal decreases expression ISO RGD:735264 6480464 butyraldehyde results in decreased expression of GSTM2 mRNA CTD PMID:26079696 butylated hydroxyanisole increases expression ISO RGD:10698 6480464 Butylated Hydroxyanisole results in increased expression of GSTM2 mRNA, Butylated Hydroxyanisole results in increased expression of GSTM2 protein CTD PMID:11991805 more ... cadmium atom multiple interactions ISO RGD:735264 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GSTM2 mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of GSTM2 mRNA CTD PMID:18636176 cadmium dichloride multiple interactions ISO RGD:735264 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of GSTM2 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:10698 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of GSTM2 mRNA CTD PMID:19840844 cadmium dichloride increases expression ISO RGD:10698 6480464 Cadmium Chloride results in increased expression of GSTM2 mRNA CTD PMID:15501611 calcitriol multiple interactions ISO RGD:735264 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GSTM2 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:735264 6480464 Calcitriol results in increased expression of GSTM2 mRNA CTD PMID:21592394 captan increases expression ISO RGD:10698 6480464 Captan results in increased expression of GSTM2 mRNA CTD PMID:31558096 carbamazepine increases expression EXP 6480464 Carbamazepine results in increased expression of GSTM2 mRNA CTD PMID:17381134 carbon nanotube decreases expression ISO RGD:10698 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 carmustine decreases nitrosation ISO RGD:735264 6480464 GSTM2 protein results in decreased nitrosation of Carmustine CTD PMID:11841793 CGP 52608 multiple interactions ISO RGD:735264 6480464 CGP 52608 promotes the reaction [RORA protein binds to GSTM2 gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions EXP 6480464 Chenodeoxycholic Acid binds to and results in decreased activity of GSTM2 protein CTD PMID:3954743 chenodeoxycholic acid multiple interactions ISO RGD:735264 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:32152650 chlordecone increases expression ISO RGD:10698 6480464 Chlordecone results in increased expression of GSTM2 mRNA CTD PMID:33711761 chlorohydrocarbon multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:30744511 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of GSTM2 mRNA CTD PMID:19440498 cholic acid multiple interactions EXP 6480464 Cholic Acid binds to and results in decreased activity of GSTM2 protein CTD PMID:3954743 cholic acid increases expression ISO RGD:10698 6480464 Cholic Acid results in increased expression of GSTM2 mRNA CTD PMID:17521389 ciglitazone decreases expression EXP 6480464 ciglitazone results in decreased expression of GSTM2 mRNA CTD PMID:22193206 cis-caffeic acid decreases activity EXP 6480464 caffeic acid results in decreased activity of GSTM2 protein CTD PMID:8340025 cisplatin affects response to substance ISO RGD:735264 6480464 GSTM2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of GSTM2 mRNA CTD PMID:20623750 clofibrate decreases expression EXP 6480464 Clofibrate results in decreased expression of GSTM2 mRNA CTD PMID:11328961 clofibrate multiple interactions ISO RGD:10698 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GSTM2 mRNA more ... CTD PMID:17585979 , PMID:22496397 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of GSTM2 mRNA CTD PMID:17602206 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of GSTM2 mRNA CTD PMID:17602206 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of GSTM2 mRNA CTD PMID:15860345 copper atom decreases expression EXP 6480464 Copper results in decreased expression of GSTM2 mRNA CTD PMID:22465980 copper atom increases expression EXP 6480464 Copper results in increased expression of GSTM2 mRNA CTD PMID:30556269 copper atom multiple interactions ISO RGD:10698 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM2 mRNA CTD PMID:15467011 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of GSTM2 mRNA CTD PMID:22465980 copper(0) increases expression EXP 6480464 Copper results in increased expression of GSTM2 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO RGD:10698 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of GSTM2 mRNA CTD PMID:15467011 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of GSTM2 mRNA, Corticosterone results in increased expression of GSTM2 protein CTD PMID:15755911 cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide results in decreased expression of GSTM2 mRNA CTD PMID:11906922 cyclosporin A multiple interactions ISO RGD:735264 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:32152650 cylindrospermopsin decreases expression ISO RGD:735264 6480464 cylindrospermopsin results in decreased expression of GSTM2 mRNA CTD PMID:23726867 , PMID:30905859 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of GSTM2 mRNA CTD PMID:25182419 cyproconazole increases expression ISO RGD:10698 6480464 cyproconazole results in increased expression of GSTM2 mRNA CTD PMID:22334560 deguelin decreases expression ISO RGD:735264 6480464 deguelin results in decreased expression of GSTM2 mRNA CTD PMID:33512557 deoxycholic acid multiple interactions ISO RGD:735264 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:32152650 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of GSTM2 mRNA] CTD PMID:20032058 dexamethasone increases expression ISO RGD:10698 6480464 Dexamethasone results in increased expression of GSTM2 mRNA CTD PMID:18723825 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of GSTM2 mRNA CTD PMID:1394205 , PMID:20032058 dexamethasone affects expression EXP 6480464 Dexamethasone affects the expression of GSTM2 mRNA CTD PMID:15102944 dextran sulfate decreases expression ISO RGD:10698 6480464 Dextran Sulfate results in decreased expression of GSTM2 mRNA CTD PMID:35093514 Diallyl sulfide increases expression ISO RGD:10698 6480464 allyl sulfide results in increased expression of GSTM2 mRNA CTD PMID:18723825 Diallyl sulfide increases expression EXP 6480464 allyl sulfide results in increased expression of GSTM2 mRNA CTD PMID:19695238 diazinon increases expression EXP 6480464 Diazinon results in increased expression of GSTM2 mRNA CTD PMID:19440498 dibutyl phthalate affects expression EXP 6480464 Dibutyl Phthalate affects the expression of GSTM2 mRNA CTD PMID:21745491 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of GSTM2 mRNA CTD PMID:21266533 dichlorine decreases expression EXP 6480464 Chlorine results in decreased expression of GSTM2 mRNA CTD PMID:18636392 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of GSTM2 mRNA CTD PMID:18636392 diclofenac decreases activity ISO RGD:735264 6480464 Diclofenac results in decreased activity of GSTM2 protein CTD PMID:27183920 dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of GSTM2 mRNA CTD PMID:22193206 diquat decreases expression EXP 6480464 Diquat results in decreased expression of GSTM2 mRNA CTD PMID:7676460 doramapimod increases expression ISO RGD:10698 6480464 doramapimod results in increased expression of GSTM2 mRNA CTD PMID:21328587 dorsomorphin multiple interactions ISO RGD:735264 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases oxidation EXP 6480464 Doxorubicin results in increased oxidation of GSTM2 protein CTD PMID:28818578 doxorubicin decreases expression ISO RGD:735264 6480464 Doxorubicin results in decreased expression of GSTM2 mRNA CTD PMID:29803840 ebselen multiple interactions EXP 6480464 ebselen binds to and results in decreased activity of [GSTM1 protein binds to GSTM2 protein] CTD PMID:8147899 epoxiconazole increases expression EXP 6480464 epoxiconazole results in increased expression of GSTM2 mRNA CTD PMID:25182419 epoxiconazole increases expression ISO RGD:10698 6480464 epoxiconazole results in increased expression of GSTM2 mRNA CTD PMID:22334560 ethanol increases expression ISO RGD:10698 6480464 Ethanol results in increased expression of GSTM2 mRNA CTD PMID:19167417 ethoxyquin increases expression EXP 6480464 Ethoxyquin results in increased expression of GSTM2 mRNA CTD PMID:19695238 ethoxyquin increases expression ISO RGD:10698 6480464 Ethoxyquin results in increased expression of GSTM2 mRNA CTD PMID:18723825 eugenol decreases activity EXP 6480464 Eugenol analog results in decreased activity of GSTM2 protein CTD PMID:8620581 felbamate increases expression EXP 6480464 felbamate results in increased expression of GSTM2 mRNA CTD PMID:17381134 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of GSTM2 mRNA CTD PMID:18253720 , PMID:18775883 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of GSTM2 mRNA CTD PMID:18775883 Fenoprop decreases expression EXP 6480464 fenoprop results in decreased expression of GSTM2 protein CTD PMID:8914623 fenpyroximate decreases expression ISO RGD:735264 6480464 fenpyroximate results in decreased expression of GSTM2 mRNA CTD PMID:33512557 fipronil increases expression EXP 6480464 fipronil results in increased expression of GSTM2 mRNA CTD PMID:23962444 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of GSTM2 mRNA CTD PMID:18035473 flutamide increases expression EXP 6480464 Flutamide results in increased expression of GSTM2 mRNA, Flutamide results in increased expression of GSTM2 protein CTD PMID:17311803 , PMID:24136188 folic acid multiple interactions ISO RGD:10698 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:22206623 folpet increases expression ISO RGD:10698 6480464 folpet results in increased expression of GSTM2 mRNA CTD PMID:31558096 fumonisin B1 increases expression ISO RGD:10698 6480464 fumonisin B1 results in increased expression of GSTM2 mRNA CTD PMID:16221962 furan decreases expression EXP 6480464 furan results in decreased expression of GSTM2 mRNA CTD PMID:25539665 Geniposide increases expression EXP 6480464 geniposide results in increased expression of GSTM2 mRNA, geniposide results in increased expression of GSTM2 protein CTD PMID:14646352 gentamycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA CTD PMID:30545405 gliotoxin decreases expression EXP 6480464 Gliotoxin results in decreased expression of GSTM2 mRNA CTD PMID:18346771 glutathione affects metabolic processing ISO RGD:735264 6480464 GSTM2 protein affects the metabolism of Glutathione CTD PMID:10858281 glutathione multiple interactions ISO RGD:735264 6480464 [GSTM2 protein co-treated with Glutathione] results in increased metabolism of amodiaquine quinoneimine, [GSTM2 protein co-treated with Glutathione] results in increased metabolism of desethylamodiaquine CTD PMID:28478157 glutathione multiple interactions EXP 6480464 Dinitrochlorobenzene promotes the reaction [GSTM2 protein affects the metabolism of Glutathione] more ... CTD PMID:2604743 more ... glutathione affects metabolic processing EXP 6480464 GSTM2 protein affects the metabolism of Glutathione CTD PMID:8924604 glycochenodeoxycholic acid multiple interactions ISO RGD:735264 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:32152650 glycocholic acid multiple interactions ISO RGD:735264 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:32152650 glycodeoxycholic acid multiple interactions ISO RGD:735264 6480464 [Cyclosporine co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA, [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:32152650 griseofulvin affects expression ISO RGD:10698 6480464 Griseofulvin affects the expression of GSTM2 mRNA CTD PMID:12735108 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of GSTM2 mRNA CTD PMID:15860345 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of GSTM2 mRNA CTD PMID:15159207 hydrazine decreases expression EXP 6480464 hydrazine results in decreased expression of GSTM2 mRNA CTD PMID:15370871 hydrogen peroxide increases expression ISO RGD:10698 6480464 Hydrogen Peroxide results in increased expression of GSTM2 mRNA CTD PMID:15003993 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of GSTM2 mRNA CTD PMID:21396975 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM2 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GSTM2 mRNA CTD PMID:22129741 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of GSTM2 mRNA CTD PMID:18299717 isomethyleugenol decreases activity EXP 6480464 isomethyleugenol results in decreased activity of GSTM2 protein CTD PMID:8620581 ivermectin decreases expression ISO RGD:735264 6480464 Ivermectin results in decreased expression of GSTM2 protein CTD PMID:32959892 kaempferol multiple interactions ISO RGD:735264 6480464 [Quercetin co-treated with kaempferol] results in increased expression of GSTM2 mRNA CTD PMID:25111660 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of GSTM2 mRNA CTD PMID:18289764 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of GSTM2 mRNA, [Diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTM2 mRNA CTD PMID:18544905 L-ascorbic acid multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of GSTM2 mRNA] CTD PMID:23470461 L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of GSTM2 mRNA CTD PMID:15372504 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of GSTM2 protein CTD PMID:9750042 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of GSTM2 protein CTD PMID:9750042 lipopolysaccharide decreases expression ISO RGD:735264 6480464 Lipopolysaccharides results in decreased expression of GSTM2 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:735264 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of GSTM2 mRNA] CTD PMID:35811015 lithocholic acid multiple interactions EXP 6480464 Lithocholic Acid binds to and results in decreased activity of GSTM2 protein CTD PMID:3954743 lithocholic acid increases expression EXP 6480464 Lithocholic Acid results in increased expression of GSTM2 mRNA CTD PMID:21311750 lithocholic acid sulfate multiple interactions EXP 6480464 sulfolithocholic acid binds to and results in decreased activity of GSTM2 protein CTD PMID:3954743 mercury dibromide decreases expression ISO RGD:735264 6480464 mercuric bromide results in decreased expression of GSTM2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:735264 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSTM2 mRNA CTD PMID:27188386 metformin decreases expression EXP 6480464 Metformin results in decreased expression of GSTM2 mRNA CTD PMID:31324951 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of GSTM2 mRNA CTD PMID:16393664 methylmercury chloride decreases expression ISO RGD:735264 6480464 methylmercuric chloride results in decreased expression of GSTM2 mRNA CTD PMID:28001369 methylmercury chloride multiple interactions EXP 6480464 [Hydrocarbons more ... CTD PMID:30744511 metronidazole multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA CTD PMID:30545405 microcystin increases expression EXP 6480464 Microcystins results in increased expression of GSTM2 mRNA CTD PMID:19790251 microcystin decreases expression EXP 6480464 Microcystins results in decreased expression of GSTM2 mRNA CTD PMID:19790251 microcystin-LR increases expression ISO RGD:10698 6480464 cyanoginosin LR results in increased expression of GSTM2 mRNA CTD PMID:17654400 monosodium L-glutamate increases expression ISO RGD:10698 6480464 Sodium Glutamate results in increased expression of GSTM2 mRNA CTD PMID:20111022 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in increased expression of GSTM2 mRNA CTD PMID:22129741 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO RGD:10698 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of GSTM2 mRNA CTD PMID:20061341 N-methyl-4-phenylpyridinium decreases expression ISO RGD:735264 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of GSTM2 protein CTD PMID:24806433 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:10698 6480464 [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in decreased expression of GSTM2 mRNA more ... CTD PMID:19840844 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of GSTM2 mRNA more ... CTD PMID:17602206 more ... N-nitrosodiethylamine multiple interactions ISO RGD:10698 6480464 [dicyclanil co-treated with Diethylnitrosamine] results in increased expression of GSTM2 mRNA more ... CTD PMID:17942915 more ... N-nitrosodiethylamine increases expression ISO RGD:10698 6480464 Diethylnitrosamine results in increased expression of GSTM2 mRNA CTD PMID:17942915 nafenopin decreases expression EXP 6480464 Nafenopin results in decreased expression of GSTM2 protein CTD PMID:8914623 naphthalene affects expression ISO RGD:10698 6480464 naphthalene affects the expression of GSTM2 protein CTD PMID:10959795 naphthalene decreases expression ISO RGD:10698 6480464 naphthalene results in decreased expression of GSTM2 mRNA CTD PMID:31020322 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of GSTM2 mRNA CTD PMID:24136188 nefazodone multiple interactions ISO RGD:735264 6480464 [nefazodone co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:32152650 neomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA CTD PMID:30545405 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of GSTM2 mRNA CTD PMID:19440498 nickel atom decreases expression ISO RGD:735264 6480464 Nickel results in decreased expression of GSTM2 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride decreases expression ISO RGD:10698 6480464 nickel chloride results in decreased expression of GSTM2 mRNA CTD PMID:14645679 nicotine decreases expression ISO RGD:10698 6480464 Nicotine results in decreased expression of GSTM2 mRNA CTD PMID:33640489 nitric oxide increases expression ISO RGD:10698 6480464 Nitric Oxide deficiency results in increased expression of GSTM2 mRNA CTD PMID:15878706 nitroglycerin affects metabolic processing EXP 6480464 GSTM2 protein affects the metabolism of Nitroglycerin CTD PMID:8968379 O-methyleugenol decreases activity EXP 6480464 methyleugenol results in decreased activity of GSTM2 protein CTD PMID:8620581 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of GSTM2 mRNA CTD PMID:24120684 ochratoxin A affects expression ISO RGD:735264 6480464 ochratoxin A affects the expression of GSTM2 mRNA CTD PMID:32905824 okadaic acid multiple interactions ISO RGD:10698 6480464 [Methylnitronitrosoguanidine co-treated with Okadaic Acid] results in decreased expression of GSTM2 mRNA CTD PMID:19840844 oltipraz multiple interactions ISO RGD:10698 6480464 [oltipraz results in increased activity of NFE2L2 protein] which results in increased expression of GSTM2 mRNA, NFE2L2 protein affects the reaction [oltipraz results in increased expression of GSTM2 mRNA] CTD PMID:22496397 oltipraz increases expression ISO RGD:10698 6480464 oltipraz results in increased expression of GSTM2 mRNA CTD PMID:18723825 , PMID:22496397 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GSTM2 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of GSTM2 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] affects the expression of GSTM2 mRNA CTD PMID:18636392 ozone multiple interactions ISO RGD:10698 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of GSTM2 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of GSTM2 mRNA CTD PMID:34911549 ozone decreases expression EXP 6480464 Ozone results in decreased expression of GSTM2 mRNA CTD PMID:16716893 paracetamol multiple interactions ISO RGD:10698 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of GSTM2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of GSTM2 mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of GSTM2 mRNA CTD PMID:18346771 , PMID:33387578 paracetamol decreases expression ISO RGD:10698 6480464 Acetaminophen results in decreased expression of GSTM2 mRNA CTD PMID:16611625 paracetamol affects expression ISO RGD:10698 6480464 Acetaminophen affects the expression of GSTM2 mRNA CTD PMID:17562736 paraoxon increases expression ISO RGD:735264 6480464 Paraoxon results in increased expression of GSTM2 CTD PMID:24486155 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of GSTM2 mRNA CTD PMID:17935786 paraquat increases expression ISO RGD:10698 6480464 Paraquat results in increased expression of GSTM2 mRNA CTD PMID:16128001 , PMID:21371552 paraquat increases expression EXP 6480464 Paraquat results in increased expression of GSTM2 mRNA CTD PMID:16555045 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 pentachlorophenol increases expression ISO RGD:10698 6480464 Pentachlorophenol results in increased expression of GSTM2 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of GSTM2 mRNA CTD PMID:19162173 perfluorooctanoic acid multiple interactions ISO RGD:10698 6480464 PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of GSTM2 mRNA], PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of GSTM2 mRNA] CTD PMID:20118188 , PMID:20936131 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of GSTM2 protein CTD PMID:34958885 perfluorooctanoic acid decreases expression ISO RGD:10698 6480464 perfluorooctanoic acid results in decreased expression of GSTM2 mRNA CTD PMID:20118188 perfluorooctanoic acid increases expression ISO RGD:10698 6480464 perfluorooctanoic acid results in increased expression of GSTM2 mRNA CTD PMID:20936131 perfluorooctanoic acid affects expression ISO RGD:10698 6480464 perfluorooctanoic acid affects the expression of GSTM2 mRNA CTD PMID:18281256 phenformin increases expression EXP 6480464 Phenformin results in increased expression of GSTM2 mRNA CTD PMID:31324951 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of GSTM2 mRNA, Phenobarbital results in increased expression of GSTM2 protein CTD PMID:12082028 more ... phenobarbital increases expression ISO RGD:735264 6480464 Phenobarbital results in increased expression of GSTM2 protein CTD PMID:28541575 phenobarbital increases expression ISO RGD:10698 6480464 Phenobarbital results in increased expression of GSTM2 mRNA, Phenobarbital results in increased expression of GSTM2 protein CTD PMID:19270015 more ... phenobarbital multiple interactions ISO RGD:10698 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of GSTM2 mRNA more ... CTD PMID:19482888 more ... phenylmercury acetate decreases expression ISO RGD:735264 6480464 Phenylmercuric Acetate results in decreased expression of GSTM2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735264 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSTM2 mRNA CTD PMID:27188386 phenytoin increases expression EXP 6480464 Phenytoin results in increased expression of GSTM2 mRNA CTD PMID:17381134 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of GSTM2 mRNA CTD PMID:33945839 phlorizin increases expression ISO RGD:10698 6480464 Phlorhizin results in increased expression of GSTM2 mRNA CTD PMID:22538082 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:10698 6480464 [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of GSTM2 mRNA CTD PMID:19840844 picoxystrobin decreases expression ISO RGD:735264 6480464 picoxystrobin results in decreased expression of GSTM2 mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:10698 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GSTM2 mRNA] CTD PMID:20059764 pirinixic acid decreases expression ISO RGD:10698 6480464 pirinixic acid results in decreased expression of GSTM2 mRNA CTD PMID:16221962 more ... potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of GSTM2 mRNA CTD PMID:23470461 potassium dichromate multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of GSTM2 mRNA] CTD PMID:23470461 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of GSTM2 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:10698 6480464 Pregnenolone Carbonitrile results in increased expression of GSTM2 mRNA CTD PMID:18723825 more ... pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:10698 6480464 [Pregnenolone Carbonitrile results in increased activity of NR1I2 protein] which results in increased expression of GSTM2 mRNA more ... CTD PMID:20693526 , PMID:22496397 progesterone affects expression ISO RGD:10698 6480464 Progesterone affects the expression of GSTM2 mRNA CTD PMID:17251523 propiconazole increases expression ISO RGD:10698 6480464 propiconazole results in increased expression of GSTM2 mRNA CTD PMID:16730040 more ... prostaglandin E2 affects chemical synthesis ISO RGD:735264 6480464 GSTM2 protein affects the chemical synthesis of Dinoprostone CTD PMID:10905636 prostaglandin H2 affects metabolic processing ISO RGD:735264 6480464 GSTM2 protein affects the metabolism of Prostaglandin H2 CTD PMID:10905636 prostaglandins E affects chemical synthesis ISO RGD:735264 6480464 GSTM2 protein affects the chemical synthesis of Prostaglandins E CTD PMID:10905636 pyrazinecarboxamide increases expression EXP 6480464 Pyrazinamide results in increased expression of GSTM2 mRNA CTD PMID:22431067 pyrimidifen decreases expression ISO RGD:735264 6480464 pyrimidifen results in decreased expression of GSTM2 mRNA CTD PMID:33512557 quercetin multiple interactions ISO RGD:735264 6480464 [Quercetin co-treated with kaempferol] results in increased expression of GSTM2 mRNA CTD PMID:25111660 Reactive blue 2 decreases activity EXP 6480464 Cibacron Blue F 3GA results in decreased activity of GSTM2 protein CTD PMID:8968379 Rebamipide increases expression EXP 6480464 rebamipide results in increased expression of GSTM2 mRNA CTD PMID:18299717 riddelliine decreases expression EXP 6480464 riddelliine results in decreased expression of GSTM2 mRNA CTD PMID:18047727 rotenone increases expression ISO RGD:10698 6480464 Rotenone results in increased expression of GSTM2 mRNA CTD PMID:23186747 rotenone decreases expression ISO RGD:735264 6480464 Rotenone results in decreased expression of GSTM2 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:735264 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in decreased expression of GSTM2 mRNA] CTD PMID:35811015 S-adenosyl-L-methioninate multiple interactions ISO RGD:10698 6480464 S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of GSTM2 mRNA] CTD PMID:18098314 S-adenosyl-L-methionine multiple interactions ISO RGD:10698 6480464 S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of GSTM2 mRNA] CTD PMID:18098314 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:10698 6480464 Buthionine Sulfoximine results in increased expression of GSTM2 mRNA CTD PMID:15878706 S-hexylglutathione decreases activity ISO RGD:735264 6480464 hexylglutathione results in decreased activity of GSTM2 protein CTD PMID:10858281 SB 431542 multiple interactions ISO RGD:735264 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:735264 6480464 Silicon Dioxide analog results in decreased expression of GSTM2 mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:10698 6480464 Silver results in increased expression of GSTM2 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:10698 6480464 Silver results in increased expression of GSTM2 mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:735264 6480464 sodium arsenite results in increased expression of GSTM2 mRNA CTD PMID:25879800 sodium arsenite multiple interactions ISO RGD:735264 6480464 sodium arsenite promotes the reaction [GSTM2 protein binds to CAPRIN1 protein] CTD PMID:33939924 sodium arsenite affects expression ISO RGD:735264 6480464 sodium arsenite affects the expression of GSTM2 mRNA CTD PMID:34032870 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of GSTM2 protein CTD PMID:29459688 sodium arsenite increases expression ISO RGD:10698 6480464 sodium arsenite results in increased expression of GSTM2 mRNA CTD PMID:14691202 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of GSTM2 mRNA CTD PMID:12325037 sodium dichromate increases expression ISO RGD:10698 6480464 sodium bichromate results in increased expression of GSTM2 mRNA CTD PMID:22155349 sodium dichromate decreases expression ISO RGD:10698 6480464 sodium bichromate results in decreased expression of GSTM2 mRNA CTD PMID:22155349 sodium fluoride decreases expression ISO RGD:10698 6480464 Sodium Fluoride results in decreased expression of GSTM2 protein CTD PMID:28918527 spironolactone increases expression ISO RGD:10698 6480464 Spironolactone results in increased expression of GSTM2 mRNA CTD PMID:18723825 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of GSTM2 mRNA CTD PMID:16684804 streptozocin multiple interactions EXP 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of GSTM2 mRNA] CTD PMID:16684804 styrene oxide affects metabolic processing EXP 6480464 GSTM2 protein affects the metabolism of styrene oxide CTD PMID:1638515 styrene oxide multiple interactions EXP 6480464 GSTM2 protein affects the metabolism of [styrene oxide co-treated with Glutathione] CTD PMID:2604743 sulfasalazine increases expression ISO RGD:10698 6480464 Sulfasalazine results in increased expression of GSTM2 mRNA CTD PMID:31830553 sulindac multiple interactions EXP 6480464 [Sulindac co-treated with lipopolysaccharide, E coli O55-B5] affects the expression of GSTM2 mRNA CTD PMID:20371263 sunitinib decreases expression ISO RGD:735264 6480464 Sunitinib results in decreased expression of GSTM2 mRNA CTD PMID:31533062 tacrine increases expression EXP 6480464 Tacrine results in increased expression of GSTM2 mRNA CTD PMID:12832660 tebuconazole increases expression ISO RGD:735264 6480464 tebuconazole results in increased expression of GSTM2 mRNA CTD PMID:30458266 tebufenpyrad decreases expression ISO RGD:735264 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of GSTM2 mRNA CTD PMID:33512557 temozolomide decreases expression ISO RGD:735264 6480464 Temozolomide results in decreased expression of GSTM2 mRNA CTD PMID:31758290 tert-butyl hydroperoxide decreases expression ISO RGD:735264 6480464 tert-Butylhydroperoxide results in decreased expression of GSTM2 mRNA, tert-Butylhydroperoxide results in decreased expression of GSTM2 protein CTD PMID:15336504 , PMID:24394546 tert-butyl hydroperoxide decreases response to substance ISO RGD:10698 6480464 GSTM2 protein results in decreased susceptibility to tert-Butylhydroperoxide CTD PMID:15003993 tert-butyl hydroperoxide increases expression ISO RGD:10698 6480464 tert-Butylhydroperoxide results in increased expression of GSTM2 mRNA CTD PMID:15003993 , PMID:15336504 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of GSTM2 protein CTD PMID:24394546 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of GSTM2 mRNA] CTD PMID:20032058 testosterone decreases expression ISO RGD:10698 6480464 Testosterone results in decreased expression of GSTM2 mRNA CTD PMID:20403060 testosterone decreases expression ISO RGD:735264 6480464 Testosterone results in decreased expression of GSTM2 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:735264 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of GSTM2 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:10698 6480464 Carbon Tetrachloride results in increased expression of GSTM2 mRNA CTD PMID:27339419 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of GSTM2 mRNA CTD PMID:17805973 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of GSTM2 mRNA CTD PMID:16239168 , PMID:18346771 theophylline decreases expression ISO RGD:735264 6480464 Theophylline results in decreased expression of GSTM2 mRNA CTD PMID:16083514 thiazoles increases expression EXP 6480464 Thiazoles results in increased expression of GSTM2 mRNA, Thiazoles results in increased expression of GSTM2 protein CTD PMID:8951341 thifluzamide decreases expression ISO RGD:735264 6480464 thifluzamide results in decreased expression of GSTM2 mRNA CTD PMID:33512557 thimerosal decreases expression ISO RGD:735264 6480464 Thimerosal results in decreased expression of GSTM2 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of GSTM2 mRNA CTD PMID:15497818 titanium dioxide increases expression ISO RGD:735264 6480464 titanium dioxide results in increased expression of GSTM2 mRNA CTD PMID:34973136 toluene affects expression EXP 6480464 Toluene affects the expression of GSTM2 mRNA CTD PMID:18653662 topotecan increases expression EXP 6480464 Topotecan results in increased expression of GSTM2 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GSTM2 mRNA CTD PMID:25729387 trans-caffeic acid decreases activity EXP 6480464 caffeic acid results in decreased activity of GSTM2 protein CTD PMID:8340025 trichostatin A affects expression ISO RGD:735264 6480464 trichostatin A affects the expression of GSTM2 mRNA CTD PMID:18664505 trichostatin A multiple interactions ISO RGD:735264 6480464 trichostatin A promotes the reaction [[decitabine affects the methylation of GSTM2 promoter] which affects the expression of GSTM2 protein] CTD PMID:18664505 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of GSTM2 mRNA CTD PMID:17381134 valproic acid affects expression ISO RGD:10698 6480464 Valproic Acid affects the expression of GSTM2 mRNA CTD PMID:17292431 , PMID:17963808 vanadyl sulfate multiple interactions EXP 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of GSTM2 mRNA] CTD PMID:16684804 vancomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA CTD PMID:30545405 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of GSTM2 mRNA CTD PMID:19015723 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of GSTM2 mRNA CTD PMID:11717422 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of GSTM2 mRNA CTD PMID:11717422